SCHEMBL31404666

SCHEMBL31404666

OC1(C2CC2)CCCNC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.33
HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22349711 0.87 MAPT (0.39) MAPT
SCHEMBL18084817 0.86 MAPT (0.35) MAPT
SCHEMBL20911099 0.86
Hydrochloric Acid SCHEMBL25311167 0.84 MAPT (0.31) MAPT
SCHEMBL17472486 0.80 MAPT (0.36) MAPT
SCHEMBL18019792 0.80 MAPT (0.36) MAPT
SCHEMBL18065630 0.76 MAPT (0.40) MAPT
SCHEMBL321458 0.75
SCHEMBL7847424 0.73
Hydrochloric Acid SCHEMBL62939 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034167-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2025-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034167-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE KRAS, NRAS, HRAS MAPT 4648/4885HTR2A 4370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.